Overview

Reducing Total Cardiovascular Risk in an Urban Community

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
0
Participant gender:
All
Summary
PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Atenolol
Lisinopril
Metoprolol
Platelet Aggregation Inhibitors
Propranolol
Criteria
Inclusion Criteria:

- Currently receiving medical care at Johns Hopkins University

- African American or Caucasian and have diagnosed CVD, defined as a prior myocardial
infarction, revascularization procedure for coronary disease, ischemic heart disease,
stroke, or have diagnosed type 2 diabetes and not receiving any therapy

- Have either no LDL-C in their medical record during the 12 months prior to study entry
or have an LDL greater than or equal to 100 mg/dl on or off lipid lowering
pharmacotherapy

- Have either no blood pressure recorded in their medical record during the 12 months
prior to study entry or a BP greater than 140/90 mmHg or greater than 130/80 mmHg if
the participant is diabetic or has renal insufficiency

- If the participant is diabetic he or she has to either have no HbA1c recorded during
the 12 months prior to study entry or HbA1c of 7 percent or greater

Exclusion criteria:

- A serious life-threatening noncardiac comorbidity with a life expectancy of less than
5 years

- A serious physician-recorded psychiatric morbidity that would interfere with the study

- Sufficient neurological impairment that would interfere with the study